Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Gene Expression Profiling of Human Melanoma Cell Lines with Distinct Metastatic Potential Identifies New Progression Markers

FRANÇOIS BERTUCCI, CÉCILE PAGES, PASCAL FINETTI, PHILIPPE ROCHAIX, LAURENCE LAMANT, ELIZABETH DEVILARD, CATHY NGUYEN, RÉMI HOULGATTE, DANIEL BIRNBAUM, LUC XERRI and PIERRE BROUSSET
Anticancer Research September 2007, 27 (5A) 3441-3449;
FRANÇOIS BERTUCCI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bertuccif@marseille.fnclcc.fr
CÉCILE PAGES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PASCAL FINETTI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILIPPE ROCHAIX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LAURENCE LAMANT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELIZABETH DEVILARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CATHY NGUYEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RÉMI HOULGATTE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIEL BIRNBAUM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LUC XERRI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PIERRE BROUSSET
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 5A 3441-3449
PubMed 
17970093

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 13, 2007
  • Revision received June 27, 2007
  • Accepted July 9, 2007
  • Published online September 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. FRANÇOIS BERTUCCI1,2,
  2. CÉCILE PAGES3,
  3. PASCAL FINETTI2,
  4. PHILIPPE ROCHAIX4,
  5. LAURENCE LAMANT3,
  6. ELIZABETH DEVILARD2,
  7. CATHY NGUYEN5,
  8. RÉMI HOULGATTE5,
  9. DANIEL BIRNBAUM2,
  10. LUC XERRI6 and
  11. PIERRE BROUSSET3
  1. 1Department of Medical Oncology, Marseille Cancer Research Center, UMR599 INSERM, Institut Paoli Calmettes, Marseille
  2. 2Department of Molecular Oncology, Marseille Cancer Research Center, UMR599 INSERM, Institut Paoli Calmettes, Marseille
  3. 3Department of Pathology, CHU Purpan Toulouse
  4. 4Department of Pathology, Institut Claudius Regaud, Toulouse
  5. 5TAGC laboratory, INSERM ERM206, Marseille, France
  6. 6Department of Biopathology, Marseille Cancer Research Center, UMR599 INSERM, Institut Paoli Calmettes, Marseille
  1. Correspondence to: Professor F. Bertucci, Department of Medical Oncology, Institut Paoli Calmettes, 232, Bd Ste-Marguerite, 13273 Marseille Cedex, France. Tel: +33 4 91 223537, Fax: +33 4 91 223670, e-mail: bertuccif{at}marseille.fnclcc.fr

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 27 (5A)
Anticancer Research
Vol. 27, Issue 5A
September-October 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Gene Expression Profiling of Human Melanoma Cell Lines with Distinct Metastatic Potential Identifies New Progression Markers
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
14 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Gene Expression Profiling of Human Melanoma Cell Lines with Distinct Metastatic Potential Identifies New Progression Markers
FRANÇOIS BERTUCCI, CÉCILE PAGES, PASCAL FINETTI, PHILIPPE ROCHAIX, LAURENCE LAMANT, ELIZABETH DEVILARD, CATHY NGUYEN, RÉMI HOULGATTE, DANIEL BIRNBAUM, LUC XERRI, PIERRE BROUSSET
Anticancer Research Sep 2007, 27 (5A) 3441-3449;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Gene Expression Profiling of Human Melanoma Cell Lines with Distinct Metastatic Potential Identifies New Progression Markers
FRANÇOIS BERTUCCI, CÉCILE PAGES, PASCAL FINETTI, PHILIPPE ROCHAIX, LAURENCE LAMANT, ELIZABETH DEVILARD, CATHY NGUYEN, RÉMI HOULGATTE, DANIEL BIRNBAUM, LUC XERRI, PIERRE BROUSSET
Anticancer Research Sep 2007, 27 (5A) 3441-3449;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness
  • Google Scholar

More in this TOC Section

  • MAP17 as a Mediator of HGF-induced Proliferation and Invasion in Gastric Cancer
  • Contribution of Methylenetetrahydrofolate Reductase Genotypes to Brain Tumor Risk Determination in Taiwan
  • Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire